443344-23-8 Usage
Uses
Used in Pharmaceutical Industry:
Benzyl-(tetrahydro-pyran-4-yl)-amine is utilized as a key intermediate in the synthesis of pharmaceuticals for its ability to form complex molecular structures that can target specific biological pathways. Its incorporation into drug molecules can enhance their efficacy and selectivity, contributing to the development of novel therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, Benzyl-(tetrahydro-pyran-4-yl)-amine serves as a crucial component in the formulation of pesticides and other crop protection agents. Its chemical properties allow for the design of compounds that can effectively target pests and diseases while minimizing environmental impact.
Used in Medicinal Chemistry:
Benzyl-(tetrahydro-pyran-4-yl)-amine is employed as a versatile building block in medicinal chemistry for its potential to interact with biological targets. This interaction is vital for the discovery and design of new drugs with improved pharmacological properties, such as increased potency, selectivity, and reduced side effects.
Used in Drug Discovery:
Benzyl-(tetrahydro-pyran-4-yl)-amine plays a significant role in drug discovery, where it is used to explore new chemical space and identify potential lead compounds. Its unique structural features enable the development of innovative drug candidates that can address unmet medical needs and offer new treatment options for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 443344-23-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,3,3,4 and 4 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 443344-23:
(8*4)+(7*4)+(6*3)+(5*3)+(4*4)+(3*4)+(2*2)+(1*3)=128
128 % 10 = 8
So 443344-23-8 is a valid CAS Registry Number.
443344-23-8Relevant academic research and scientific papers
GLYCINE TRANSPORTER INHIBITING SUBSTANCES
-
Page/Page column 8, (2012/01/15)
The present invention aims to provide novel compounds of formula [I] or pharmaceutically acceptable salts thereof that are based on a glycine uptake inhibiting action and which are useful in the prevention or treatment of such diseases as schizophrenia, Alzheimer's disease, cognitive dysfunction, dementia, anxiety disorders (generalized anxiety disorder, panic disorder, obsessive-compulsory disorder, social anxiety disorder, posttraumatic stress disorder, specific phobia, acute stress disorder, etc.), depression, drug addiction, spasm, tremor, and sleep disorder:
